209 related articles for article (PubMed ID: 24840325)
1. Minocycline pharmacokinetics and pharmacodynamics in dogs: dosage recommendations for treatment of meticillin-resistant Staphylococcus pseudintermedius infections.
Maaland MG; Guardabassi L; Papich MG
Vet Dermatol; 2014 Jun; 25(3):182-e47. PubMed ID: 24840325
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of canine-specific minocycline and doxycycline susceptibility breakpoints for meticillin-resistant Staphylococcus pseudintermedius isolates from dogs.
Hnot ML; Cole LK; Lorch G; Papich MG; Rajala-Schultz PJ; Daniels JB
Vet Dermatol; 2015 Oct; 26(5):334-8, e70-1. PubMed ID: 26216025
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs.
Valentine BK; Dew W; Yu A; Weese JS
Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904
[TBL] [Abstract][Full Text] [Related]
4. Prior antibacterial drug exposure in dogs with meticillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma.
Hensel N; Zabel S; Hensel P
Vet Dermatol; 2016 Apr; 27(2):72-8e20. PubMed ID: 26909526
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and methicillin resistance in Staphylococcus pseudintermedius and Staphylococcus schleiferi subsp. coagulans isolated from dogs with pyoderma in Japan.
Kawakami T; Shibata S; Murayama N; Nagata M; Nishifuji K; Iwasaki T; Fukata T
J Vet Med Sci; 2010 Dec; 72(12):1615-9. PubMed ID: 20703027
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of minocycline susceptibility of methicillin-resistant Staphylococcus pseudintermedius.
Weese JS; Sweetman K; Edson H; Rousseau J
Vet Microbiol; 2013 Mar; 162(2-4):968-971. PubMed ID: 23107659
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates.
Boyen F; Verstappen KM; De Bock M; Duim B; Weese JS; Schwarz S; Haesebrouck F; Wagenaar JA
Vet Dermatol; 2012 Aug; 23(4):381-5, e70. PubMed ID: 22409321
[TBL] [Abstract][Full Text] [Related]
8. Prior antimicrobial use as a risk factor for resistance in selected Staphylococcus pseudintermedius isolates from the skin and ears of dogs.
Zur G; Gurevich B; Elad D
Vet Dermatol; 2016 Dec; 27(6):468-e125. PubMed ID: 27870236
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of meticillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma.
Beck KM; Waisglass SE; Dick HL; Weese JS
Vet Dermatol; 2012 Aug; 23(4):369-75, e66-7. PubMed ID: 22364707
[TBL] [Abstract][Full Text] [Related]
10. In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs.
Song CY; Nam EH; Park SH; Hwang CY
Vet Dermatol; 2013 Aug; 24(4):404-8, e87. PubMed ID: 23772881
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.
Maaland MG; Papich MG; Turnidge J; Guardabassi L
J Clin Microbiol; 2013 Nov; 51(11):3547-54. PubMed ID: 23966509
[TBL] [Abstract][Full Text] [Related]
12. Effect of feeding on the pharmacokinetics of oral minocycline in healthy research dogs.
Hnot ML; Cole LK; Lorch G; Rajala-Schultz PJ; Papich MG
Vet Dermatol; 2015 Dec; 26(6):399-405, e92-3. PubMed ID: 26283447
[TBL] [Abstract][Full Text] [Related]
13. Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease.
Papich MG
Parasit Vectors; 2017 Nov; 10(Suppl 2):493. PubMed ID: 29143669
[TBL] [Abstract][Full Text] [Related]
14. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance.
Fitzgerald JR
Vet Dermatol; 2009 Oct; 20(5-6):490-5. PubMed ID: 20178486
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.
Clark SM; Loeffler A; Bond R
J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003
[TBL] [Abstract][Full Text] [Related]
16. Effect of sucralfate on oral minocycline absorption in healthy dogs.
KuKanich K; KuKanich B; Harris A; Heinrich E
J Vet Pharmacol Ther; 2014 Oct; 37(5):451-6. PubMed ID: 24611544
[TBL] [Abstract][Full Text] [Related]
17. Risk of colonization or gene transfer to owners of dogs with meticillin-resistant Staphylococcus pseudintermedius.
Frank LA; Kania SA; Kirzeder EM; Eberlein LC; Bemis DA
Vet Dermatol; 2009 Oct; 20(5-6):496-501. PubMed ID: 20178487
[TBL] [Abstract][Full Text] [Related]
18. Lincosamide resistance is less frequent in Denmark in Staphylococcus pseudintermedius from first-time canine superficial pyoderma compared with skin isolates from clinical samples with unknown clinical background.
Larsen R; Boysen L; Berg J; Guardabassi L; Damborg P
Vet Dermatol; 2015 Jun; 26(3):202-5, e43-4. PubMed ID: 25891140
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of oral pradofloxacin administration in dogs.
Boothe DM; Bush KM; Boothe HW; Davis HA
Am J Vet Res; 2018 Dec; 79(12):1268-1276. PubMed ID: 30457901
[TBL] [Abstract][Full Text] [Related]
20. In vitro bactericidal activity of blue light (465 nm) phototherapy on meticillin-susceptible and meticillin-resistant Staphylococcus pseudintermedius.
Schnedeker AH; Cole LK; Lorch G; Diaz SF; Bonagura J; Daniels JB
Vet Dermatol; 2017 Oct; 28(5):463-e106. PubMed ID: 28543810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
